ARS Pharmaceuticals, Inc. (SPRY)
4.035
-0.12
(-2.77%)
USD |
NASDAQ |
Sep 25, 15:30
ARS Pharmaceuticals Cash and Short Term Investments (Quarterly) : 143.84M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 143.84M |
| March 31, 2026 | 200.97M |
| December 31, 2025 | 244.99M |
| September 30, 2025 | 288.21M |
| June 30, 2025 | 240.13M |
| March 31, 2025 | 275.73M |
| December 31, 2024 | 314.02M |
| September 30, 2024 | 204.62M |
| June 30, 2024 | 218.74M |
| March 31, 2024 | 223.63M |
| December 31, 2023 | 228.36M |
| September 30, 2023 | 241.90M |
| June 30, 2023 | 252.21M |
| March 31, 2023 | 264.55M |
| Date | Value |
|---|---|
| December 31, 2022 | 274.38M |
| September 30, 2022 | 266.62M |
| June 30, 2022 | 257.98M |
| March 31, 2022 | 253.85M |
| December 31, 2021 | 60.06M |
| September 30, 2021 | 300.66M |
| June 30, 2021 | 359.69M |
| March 31, 2021 | 374.20M |
| December 31, 2020 | 386.57M |
| September 30, 2020 | 142.32M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 9.976M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 237.93M |
| Passage Bio, Inc. | 24.16M |
| Sionna Therapeutics, Inc. | 211.03M |
| Vertex Pharmaceuticals, Inc. | 7.863B |
| Ardelyx, Inc. | 281.83M |